CD68 and neoplasm: All patients with the immune-high subtype exhibited more than three immune clusters within the tumor, which were characterized by CD20-positive B cells surrounded by a high number of CD3-positive T cells, and rare cells positive for CD68 and/or CD163 (Figure 3).